Payer Perspectives

A CHOICE to Learn: What Health System Executives Need to Know about ICHRA

Health system leaders should assess how CHOICE could affect payer mix, reimbursement, margins, and strategy as employers rethink health coverage.

KauffmanBlog
By Joyjit Saha Choudhury
6 min readNov 18, 2026
Strategy partnerships and innovation
Key points
  •  

A CHOICE to Learn: What Health Systems Executives Need to Know about ICHRA

Just as health system executives started getting familiar with ICHRA (Individual Coverage Health Reimbursement Arrangements), the name changed. The Centers for Medicare and Medicaid Services in September unveiled CHOICE, or Custom Health Option and Individual Care Expense Arrangement. While the underpinning rules haven’t changed, there’s renewed attention on the model that comes with any rebranding. Coupled with open enrollment season, now is a good moment to reexamine what the model means for health systems and how leaders can brace for potential changes in their markets.

What is CHOICE or ICHRA? Is this a new thing? Is it popular?

U.S. employers have long played a dual role in the health insurance of their employees –designing benefits and offering a range of health plan options as well as paying for health insurance coverage. Traditionally, these two roles have been tied at the hip.

ICHRA changed the dynamic when it launched in 2020 and enabled employers to make tax deductible contributions to employees’ accounts to pay for healthcare without buying or selecting health insurance plan options for them. Depending on the specifics of the arrangements, employees are free to use the dollars to buy coverage either on the health insurance exchanges (HIX) or other off-exchange health plans, as well as pay for out-of-pocket (OOP) healthcare costs.

For many employers and industry observers, this is the elegant “defined contribution for healthcare” option they have been waiting for, akin to the 401(k) revolution that moved US pensions from a defined benefit to a defined contribution market.

CHOICE is still in an early stage of evolution and reliable data on uptake is hard to come by. The HRA Council estimates that there are at least 500,000 covered lives in a CHOICE arrangement. HealthSherpa puts the number between 400,000 and 800,000. In any case, it appears CHOICE arrangements likely cover less than 1% of the commercial employer lives in the market currently.

But the Trump administration’s rebranding in September was accompanied by CMS and Small Business Administration national information campaign. And while the name change may appear symbolic, symbols can be powerful, and it bolsters the market in three ways:

  • Signals that the administration remains highly supportive of the concept – at least philosophically for now with potentially more substantive changes to come when they have an opportunity. An early draft of the One Big Beautiful Bill Act sought to codify the model into law and create new flexibilities.
  • Helps with potential member/prospect marketing – after all, the lay person or small employer may not know what ICHRA is, but how could one not want CHOICE!
  • Generates marketing buzz in the industry which will provide a boost to the CHOICE platform players.

What are the implications of CHOICE for health systems?

Future growth potential of CHOICE should not be underestimated. Employers have been dealing with high growth rates for health benefits for decades and recent years have been particularly challenging. Employer contributions toward family coverage were estimated to reach $20,833 in 2026, up from $12,948 in 2016, according to KFF.

One could see how more employers may feel they cannot afford the current way of providing health benefits and opt to transition to CHOICE to effectively cap their contribution to employee healthcare at a fixed dollar budget (say $5,000 per employee) and let the employee pick the plan that works best for them.

This is where health system leaders need to be keenly aware of what’s happening in their market. Once employees are managing their own healthcare budget and on the hook to pay more of the plan premium, there are risks of them choosing higher cost-sharing plans—higher deductibles, copays, and coinsurance. Greater price sensitivity could lead to care avoidance and potentially delayed diagnoses of health conditions and more careful “shopping” behavior when seeking care.

For health systems, CHOICE represents yet another challenge in the larger ongoing shift in industry payer mix away from hitherto generous commercial group coverage. Health systems could find their reimbursements transitioning from the typically higher commercial employer group coverage levels to the lower levels prevalent in the individual market as employees use their CHOICE dollars to purchase health plans in the individual exchange or off-exchange market. Moreover, if they choose higher cost-sharing plans, health systems can expect more challenges with bad debt.

Rising bad debt and charity care, along with payer mix changes are already contributing factors in the tight margin environment facing health systems. Our latest National Hospital Flash Report showed that year-to-date margins were 2.5%, down from 3.6% during in 2025.

On the positive side, for some health systems, this may well be the added impetus or burning platform needed to urgently pursue alternative business models like direct-to-employer models that preserve the attractive employer-sponsored healthcare market, as well as redesign their care and operating models and associated cost structures to cater to the needs of the new growing but lower reimbursement coverage populations.

Should I be watchful? Worried? What should I do?

Be watchful? Definitely. Be worried? Potentially.

At a minimum, health system executives should educate themselves and their teams about the CHOICE model and what it could mean for them. The next step would be to estimate the current uptake of CHOICE in their markets, conduct market research with stakeholders, including employers and brokers, and develop scenarios of future uptake and financial modeling of the impact of increased uptake on the organization’s financials. These types of analyses will help leaders gauge the impact of CHOICE on their operations. When that insight is combined with other areas that require action like growth in Medicare Advantage and further site-neutral payments, health systems can then develop an appropriate portfolio of strategies to collectively address these trends.

While CHOICE arrangements cover less than 1% of the commercial employer market lives today, they represent a powerful idea with potentially challenging economics for health systems. Growth may be gradual, but leaders can’t rule out a bellwether large employer opting for CHOICE and sharply increasing the growth of the market; or more small and mid-sized employers throwing in the towel with the incessant growth in healthcare benefits costs.

Recall that 401(k)s started as a niche product, too. But within a decade, they had overtaken pension programs and are now the norm. CHOICE may not follow that exact trajectory, but health system executives would be well advised to be prepared.

The author would like to thank Matthew Weinstock for his helpful comments and edits on this piece.

Author

Smiling professional man in business suit

Joyjit Saha Choudhury

Managing Director, Strategy & Business Transformation

Joyjit Saha Choudhury is a Managing Director with Kaufman Hall in the firm’s Strategy & Business Transformation practice. Joyjit has more than 25 years of consulting experience leading engagements in the areas of payer-provider strategy, value-based care and payment, medical and network management and Medicare/Medicaid managed care strategy/performance improvement. His responsibilities include developing value-based market strategies between payers and providers...